Murine cytochrome P4503A is induced by 2-methyl-3-buten-2-ol, 3-methyl-1-pentyn-3-ol(meparfynol), and tert-amyl alcohol

Xenobiotica

Volumn 26, Issue 5, 1996, Pages 487-493

  Mannering, Gilbert J ^a   Shoeman, Janice A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMULUS LUPULUS; MURINAE;

2 METHYL 3 BUTEN 2 OL; ALKENE; ANILINE; BENZO[A]PYRENE; CYTOCHROME P450; ETHYLMORPHINE N DEMETHYLASE; HUMULON; HYDROXYL RADICAL; LUPULON; METHYLPENTYNOL; PENTANOL; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; ENZYME ACTIVITY; ENZYME INDUCTION; HYDROXYLATION; IMMUNOBLOTTING; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; SACCHAROMYCES CEREVISIAE;

ANILINE COMPOUNDS; ANIMALS; BLOTTING, WESTERN; CYCLOHEXANONES; ETHYLMORPHINE; HYDROXYLATION; MALE; METHYLATION; MICE; PENTANOLS;

EID: 0029882950     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046726     Document Type: Article

References (16)

1. COHEN, G. M., and MANNERING, G. J., 1973, Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols. Molecular Pharmacology, 9, 383-397.
2. GONZALEZ, J., 1989, The molecular biology of cytochrome P450s. Pharmacology Reviews, 40, 243-288.
3. HANSEL, R., WOHLFART, R., and SCHMIDT, H., 1982, Nachweis sedativ-hypnotischer Wirkstoffe im Hopfen. 3. Mitteilung: Der Gehalt von Hopfen und Hopfenzubereitungen an 2-Methyl-3-buten-2-ol. Plant Medica, 45, 224-228.
4. IBA, M. M., GANDER, J. E., and MANNERING, G. J., 1993, Lipid peroxidation-cytochrome P450 interactions. Use of linoleic acid hydroperoxide in the characterization of the spin state of membrane-bound P450. Xenobiotica, 23, 227-239.
5. JEFFERY, E. H., and MANNERING, G. J., 1983, Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Molecular Pharmacology, 23, 748-757.
6. KITADA, M., KOMORI, M., OHI, H., IMAOKA, Y., S., FUNAE, Y., and KAMATAKI, T., 1989, Form-specific degradation of cytochrome P-450 by lipid peroxidation in rat liver microsomes. Research Communications in Chemical Pathology and Pharmacology, 63, 175-187.
7. MANNERING, G. J., DELORIA, L. B., SHOEMAN, J. A., and NUTTER, L. M., 1993, Effects of the hop component, colupulone, on the induction of cytochrome P4503A and the replication of human tumour cells. In Food, Nutrition and Chemical Toxicity, edited by D. V. Parke, C. Ioannides and R. Walker (Japan: Nishimura Company Ltd (Smith-Gordon)), pp. 311-322.
8. MANNERING, G. J., SHOEMAN, J. A., and DELORIA, L. B., 1992, Identification of the antibiotic hops component, colupulone, as an inducer of hepatic cytochrome P4503A in the mouse. Drug Metabolism and Disposition, 20, 142-147.
9. NEBERT, W., and GONZALEZ, F. J., 1987, P450 genes: structure, evolution, and regulation. Annual Reviews of Biochemistry, 56, 945-993.
10. ORTIZ DE MONTELLANO, P. R., 1985, Alkenes and alkynes. In Bioactivation of Foreign Compounds, edited by M. W. Anders (Orlando: Academic), pp. 121-155.
11. ORTIZ DE MONTELLANO, P. R., and CORREIA, M. A., 1983, Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annual Reviews in Pharmacology and Toxicology, 23, 481-503.
12. RETTIE, A. E., BOBERG, M., RETTENMEIER, A. W., and BAILLIE, T. A., 1988, Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Journal of Biological Chemistry, 263, 13733-13738.
13. 4- VPA, a toxic metabolite of valproic acid. Science, 235, 890-893.
14. TRUSH, M. A., and T. W. KENSLER, T. W., 1991, An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radicals in Biology and Medicine, 10, 201-209.
15. WOHLFART, R., HANSEL, R., and SCHMIDT, H., 1983a, Nachweis sedativ-hypnotischer Wirkstoffe im Hopfen. 4. Mitteilung: Die Pharmakologie des Hopfeninhaltsstoffes 2-methyl-3-buten-2-ol. Journal of Medicinal Plant Research, 48, 120-123.
16. WOHLFART, R., WURM, G., HANSEL, R., and SCHMIDT, H., 1983b, Der Abbau der Bittersauren zum 2-Methyl-3-buten-2-ol, einem Hopfeninhaltsstoff mit sedativ-hypnotischer Wirkung. Archiv der Pharmazie, 316, 132-137.